World's Best Scientists 2026 revealed!
Award Badge
Best Female Scientists
2025
Award Badge
Neuroscience
USA
2026

D-Index & Metrics

Best Female Scientists

D-Index
144
Citations
97604
World Ranking
186
National Ranking
114

Neuroscience

D-Index
145
Citations
107946
World Ranking
166
National Ranking
105

Medicine

D-Index
145
Citations
108043
World Ranking
1358
National Ranking
790

Reisa A. Sperling publication distribution in Neuroscience in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Neuroscience in 2026. The highlighted bar marks where Reisa A. Sperling sits on this spectrum.

38–47 publications: 18 scientists 48–57 publications: 79 scientists 58–67 publications: 193 scientists 68–77 publications: 323 scientists 78–87 publications: 406 scientists 88–97 publications: 452 scientists 98–107 publications: 539 scientists 108–117 publications: 505 scientists 118–127 publications: 522 scientists 128–137 publications: 469 scientists 138–147 publications: 456 scientists 148–157 publications: 459 scientists 158–167 publications: 397 scientists 168–177 publications: 383 scientists 178–187 publications: 350 scientists 188–197 publications: 302 scientists 198–207 publications: 306 scientists 208–217 publications: 262 scientists 218–227 publications: 242 scientists 228–237 publications: 220 scientists 238–247 publications: 203 scientists 248–257 publications: 174 scientists 258–267 publications: 176 scientists 268–277 publications: 175 scientists 278–287 publications: 125 scientists 288–297 publications: 116 scientists 298–307 publications: 127 scientists 308–317 publications: 128 scientists 318–327 publications: 99 scientists 328–337 publications: 89 scientists 338–347 publications: 78 scientists 348–357 publications: 96 scientists 358–367 publications: 66 scientists 368–377 publications: 59 scientists 378–387 publications: 65 scientists 388–397 publications: 54 scientists 398–407 publications: 48 scientists 408–417 publications: 49 scientists 418–427 publications: 34 scientists 428–437 publications: 31 scientists 438–447 publications: 30 scientists 448–457 publications: 31 scientists 458–467 publications: 36 scientists 468–477 publications: 40 scientists 478–487 publications: 35 scientists 488–497 publications: 30 scientists 498–507 publications: 23 scientists 508–517 publications: 26 scientists 518–527 publications: 20 scientists 528–537 publications: 23 scientists 538–547 publications: 20 scientists 548–557 publications: 20 scientists 558–567 publications: 17 scientists 568–577 publications: 14 scientists 578–587 publications: 20 scientists 588–597 publications: 20 scientists 598–607 publications: 19 scientists 608–617 publications: 18 scientists 618–627 publications: 17 scientists 628–637 publications: 11 scientists 638–647 publications: 11 scientists 648–657 publications: 11 scientists 658–667 publications: 8 scientists 668–677 publications: 7 scientists 678–687 publications: 11 scientists 688–697 publications: 10 scientists 698–707 publications: 4 scientists 708–717 publications: 6 scientists 718–727 publications: 5 scientists 728–737 publications: 5 scientists 738–747 publications: 9 scientists 748–757 publications: 9 scientists 758–767 publications: 3 scientists 768–777 publications: 7 scientists 778–787 publications: 7 scientists 788–797 publications: 6 scientists 798–807 publications: 2 scientists 808–817 publications: 2 scientists 818–827 publications: 7 scientists 828–837 publications: 0 scientists 838–847 publications: 9 scientists 848–857 publications: 3 scientists 858–867 publications: 1 scientists 868–877 publications: 3 scientists 878–886 publications: 6 scientists 887+ publications: 100 scientists
38 publications 887+

This scientist: 770 publications — 98th percentile

98% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 887 publications or more.

Reisa A. Sperling D-index placement in Neuroscience in 2026

The chart shows the D-index (discipline H-index) distribution of Neuroscience scientists ranked by Research.com in 2026. The highlighted bar marks where Reisa A. Sperling sits on this spectrum.

30–31 D-Index: 42 scientists 32–33 D-Index: 172 scientists 34–35 D-Index: 296 scientists 36–37 D-Index: 435 scientists 38–39 D-Index: 459 scientists 40–41 D-Index: 456 scientists 42–43 D-Index: 467 scientists 44–45 D-Index: 478 scientists 46–47 D-Index: 512 scientists 48–49 D-Index: 435 scientists 50–51 D-Index: 425 scientists 52–53 D-Index: 418 scientists 54–55 D-Index: 392 scientists 56–57 D-Index: 357 scientists 58–59 D-Index: 334 scientists 60–61 D-Index: 328 scientists 62–63 D-Index: 260 scientists 64–65 D-Index: 278 scientists 66–67 D-Index: 239 scientists 68–69 D-Index: 250 scientists 70–71 D-Index: 210 scientists 72–73 D-Index: 200 scientists 74–75 D-Index: 189 scientists 76–77 D-Index: 170 scientists 78–79 D-Index: 146 scientists 80–81 D-Index: 113 scientists 82–83 D-Index: 126 scientists 84–85 D-Index: 100 scientists 86–87 D-Index: 84 scientists 88–89 D-Index: 99 scientists 90–91 D-Index: 84 scientists 92–93 D-Index: 85 scientists 94–95 D-Index: 72 scientists 96–97 D-Index: 76 scientists 98–99 D-Index: 45 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 43 scientists 104–105 D-Index: 32 scientists 106–107 D-Index: 45 scientists 108–109 D-Index: 50 scientists 110–111 D-Index: 32 scientists 112–113 D-Index: 39 scientists 114–115 D-Index: 32 scientists 116–117 D-Index: 29 scientists 118–119 D-Index: 27 scientists 120–121 D-Index: 19 scientists 122–123 D-Index: 23 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 16 scientists 128–129 D-Index: 24 scientists 130–131 D-Index: 13 scientists 132–133 D-Index: 21 scientists 134–135 D-Index: 17 scientists 136–137 D-Index: 14 scientists 138–139 D-Index: 15 scientists 140–141 D-Index: 10 scientists 142–143 D-Index: 10 scientists 144–145 D-Index: 13 scientists 146–147 D-Index: 9 scientists 148–149 D-Index: 8 scientists 150–151 D-Index: 6 scientists 152–153 D-Index: 6 scientists 154–155 D-Index: 7 scientists 156–157 D-Index: 7 scientists 158–159 D-Index: 10 scientists 160–161 D-Index: 4 scientists 162 D-Index: 8 scientists 163+ D-Index: 100 scientists
30 D-Index 163+

This scientist: 145 D-Index — 98th percentile

98% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 163 D-Index or more.

Research.com Recognitions

  • 2026 - Research.com Neuroscience in United States Leader Award
  • 2025 - Research.com Best Female Scientists Award
  • 2025 - Research.com Neuroscience in United States Leader Award
  • 2015 - Sedgwick Memorial Medal, American Public Health Association
  • 2015 - Potamkin Prize for Research in Pick's, Alzheimer's, and Related Diseases, American Academy of Neurology

Overview

Reisa A. Sperling is affiliated with Brigham and Women's Hospital in the United States and has an extensive research portfolio primarily focused on dementia, cognitive impairment, and Alzheimer's disease. Their scholarly contributions span multiple significant topics, including dementia and cognitive impairment research, Alzheimer's disease research and treatments, functional brain connectivity studies, advanced neuroimaging techniques and applications, health systems and economic evaluations with quality of life considerations, health, environment, cognitive aging, and cancer-related cognitive impairment studies.

Their work is most frequently published in notable venues such as Alzheimer's & Dementia, The Journal of Prevention of Alzheimer's Disease, JAMA Neurology, Alzheimer's Research & Therapy, and bioRxiv (Cold Spring Harbor Laboratory). These platforms reflect their active engagement in the field of medicine and related subfields.

Reisa A. Sperling's main fields and subfields of study include:

  • Medicine
  • Psychiatry and Mental Health
  • Physiology
  • Cognitive Neuroscience
  • Radiology, Nuclear Medicine and Imaging
  • Neurology

Their recent significant publications include the following:

  • "Revised criteria for diagnosis and staging of Alzheimer's disease: Alzheimer's Association Workgroup" (2024), Alzheimer's & Dementia
  • "The Alzheimer's Association appropriate use recommendations for blood biomarkers in Alzheimer's disease" (2022), Alzheimer's & Dementia
  • "Amyloid and tau PET-positive cognitively unimpaired individuals are at high risk for future cognitive decline" (2022), Nature Medicine
  • "Association of Factors With Elevated Amyloid Burden in Clinically Normal Older Individuals" (2020), JAMA Neurology
  • "Trial of Solanezumab in Preclinical Alzheimer's Disease" (2023), New England Journal of Medicine

Frequent collaborators in their research include Keith A. Johnson, Dorene M. Rentz, Rachel F. Buckley, Aaron P. Schultz, and Michael J Properzi.

Awards recognizing their contributions include the Potamkin Prize for Research in Pick's, Alzheimer's, and Related Diseases from the American Academy of Neurology in 2015, and the Sedgwick Memorial Medal from the American Public Health Association in the same year.

Best Publications

  • NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease

    Clifford R. Jack;David A. Bennett;Kaj Blennow;Maria C. Carrillo

  • Toward defining the preclinical stages of Alzheimer's disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease

    Reisa A. Sperling;Paul S. Aisen;Laurel A. Beckett;David A. Bennett

  • Clinical and Biomarker Changes in Dominantly Inherited Alzheimer’s Disease

    Randall J. Bateman;Chengjie Xiong;Tammie L.S. Benzinger;Anne M. Fagan

  • Cortical Hubs Revealed by Intrinsic Functional Connectivity: Mapping, Assessment of Stability, and Relation to Alzheimer's Disease

    Randy L. Buckner;Jorge Sepulcre;Tanveer Talukdar;Fenna M. Krienen

  • A conceptual framework for research on subjective cognitive decline in preclinical Alzheimer's disease

    Frank Jessen;Frank Jessen;Rebecca E. Amariglio;Martin van Boxtel;Monique Breteler

  • Introduction to the recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease

    Clifford R. Jack;Marilyn S. Albert;David S. Knopman;Guy M. McKhann

  • Two Phase 3 Trials of Bapineuzumab in Mild-to-Moderate Alzheimer's Disease

    Stephen Salloway;Reisa Sperling;Nick C. Fox;Kaj Blennow

  • Preclinical Alzheimer's disease: Definition, natural history, and diagnostic criteria.

    Bruno Dubois;Harald Hampel;Harald Hampel;Howard H. Feldman;Philip Scheltens

  • Defeating Alzheimer's disease and other dementias: a priority for European science and society

    Bengt Winblad;Bengt Winblad;Philippe Amouyel;Sandrine Andrieu;Clive Ballard

  • A/T/N: An unbiased descriptive classification scheme for Alzheimer disease biomarkers

    Clifford R. Jack;David A. Bennett;Kaj Blennow;Maria C. Carrillo

  • Limbic-predominant age-related TDP-43 encephalopathy (LATE): consensus working group report.

    Peter T. Nelson;Dennis W. Dickson;John Q. Trojanowski;Clifford R. Jack

  • The Cortical Signature of Alzheimer's Disease: Regionally Specific Cortical Thinning Relates to Symptom Severity in Very Mild to Mild AD Dementia and is Detectable in Asymptomatic Amyloid-Positive Individuals

    Bradford C. Dickerson;Akram Bakkour;David H. Salat;Eric Feczko

  • Tau positron emission tomographic imaging in aging and early Alzheimer disease

    Keith A. Johnson;Aaron Schultz;Rebecca A. Betensky;J. Alex Becker

  • Early role of vascular dysregulation on late-onset Alzheimer’s disease based on multifactorial data-driven analysis

    Y. Iturria-Medina;R. C. Sotero;P. J. Toussaint;J. M. Mateos-Pérez

  • Amyloid deposition is associated with impaired default network function in older persons without dementia

    Reisa A. Sperling;Reisa A. Sperling;Peter S. LaViolette;Kelly O'Keefe;Jacqueline O'Brien

  • Increased hippocampal activation in mild cognitive impairment compared to normal aging and AD

    B. C. Dickerson;D. H. Salat;D. N. Greve;E. F. Chua

  • Alterations in Memory Networks in Mild Cognitive Impairment and Alzheimer's Disease: An Independent Component Analysis

    Kim A. Celone;Vince D. Calhoun;Bradford C. Dickerson;Alireza Atri

  • A phase 2 multiple ascending dose trial of bapineuzumab in mild to moderate Alzheimer disease.

    S. Salloway;R. Sperling;S. Gilman;N.C.I. Fox

  • Brain Imaging in Alzheimer Disease

    Keith A. Johnson;Nick C. Fox;Reisa A. Sperling;William E. Klunk

  • Cerebral amyloid angiopathy and Alzheimer disease — one peptide, two pathways

    Steven M. Greenberg;Brian J. Bacskai;Mar Hernandez-Guillamon;Jeremy Pruzin

  • The A4 Study: Stopping AD Before Symptoms Begin?

    Reisa A. Sperling;Dorene M. Rentz;Dorene M. Rentz;Keith A. Johnson;Keith A. Johnson;Jason Karlawish

Frequent Co-Authors

Keith A. Johnson
Keith A. Johnson Harvard University
Dorene M. Rentz
Dorene M. Rentz Harvard Medical School
Rebecca Amariglio
Rebecca Amariglio Harvard Medical School
Aaron P. Schultz
Aaron P. Schultz Harvard University
Gad A. Marshall
Gad A. Marshall Brigham and Women's Hospital
Jasmeer P. Chhatwal
Jasmeer P. Chhatwal Harvard University
Kathryn V. Papp
Kathryn V. Papp Harvard University
Paul S. Aisen
Paul S. Aisen University of Southern California
Stephen Salloway
Stephen Salloway Brown University
Elizabeth C. Mormino
Elizabeth C. Mormino Stanford University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you're considering a future in neuroscience, exploring accelerated programs online can help you earn your degree faster and launch your career sooner. These programs let you balance your studies with personal and professional commitments, making them a flexible option for aspiring neuroscientists.

Neuroscience often overlaps with some of the best bachelor degrees in terms of earning potential and job prospects. Majors like biomedical engineering, computer science, and data science are among the most profitable majors, and skills in these fields can complement neuroscience careers in research, healthcare, and technology.

For those concerned about tuition costs, there are also options among the cheapest online colleges that accept fafsa. This can make a neuroscience degree more affordable and accessible, especially when combined with scholarships and federal aid. Exploring these pathways can help you make informed decisions for both your education and future career.

Best Scientists Citing Reisa A. Sperling

Trending Scientists